IPO - Cardio Diagnostics Holdings, Inc.

Form Type: CORRESP

Filing Date: 2025-02-13

Corporate Action: Ipo

Type: New

Accession Number: 000107997325000199

Filing Summary: Cardio Diagnostics Holdings, Inc. submitted a correspondence to the U.S. Securities and Exchange Commission (SEC) on February 13, 2025, requesting acceleration of their Registration Statement on Form S-3 (File No. 333-284775). The company has requested that the Registration Statement be declared effective on February 14, 2025, at 5 p.m. Eastern Time, or as soon thereafter as practicable. They mentioned that once the Registration Statement is declared effective, confirmation of this event should be provided to their counsel, Shartsis Friese LLP, specifically to Rupert Russell. The request is made in accordance with Rule 461 under the Securities Act of 1933, indicating the company's intention to proceed with an initial public offering (IPO).

Document Link: View Document